Author

Y. Banz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Angelillo-Scherrer· 1 shared A. Gazdhar· 1 shared A. Tardivel· 1 shared C. Hirzel· 1 shared C. Riether· 1 shared E. C.-W. Yu· 1 shared E. Szegezdi· 1 shared E. Youd· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Angelillo-Scherrer

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Natural killer cell-mimic nanoparticles can actively target and kill acute myeloid leukemia cells

H. Alizadeh Zeinabad, W. J. Yeoh, M. Lomora, Y. Banz, C. Riether, P. Krebs, E. Szegezdi

This study develops NK cell-mimic nanoparticles that target and kill AML cells by combining TRAIL cytotoxicity and CD16-based antibody recognition.

bioRxiv · Sep 9, 2022Cancer Biology

LRR protein RNH1 dampens the inflammasome activation and is associated with adverse clinical outcomes in COVID-19 patients

G. Bombaci, M. A. Sarangdhar, N. Andina, A. Tardivel, E. C.-W. Yu, G. M. Mackie, M. Pugh, V. B. Ozan, Y. Banz, T. Spinetti, C. Hirzel, E. Youd, J. C. Schefold, G. S. Taylor, A. Gazdhar, , R. Allam

This study identifies RNH1 as an inhibitor of inflammasome activation, showing its protective role in limiting inflammation and its association with worse outcomes in COVID-19.

bioRxiv · Apr 12, 2021 · PreprintImmunology